Locations:
SearchAdvertisement
Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access
Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Long-term relationship building and engagement key to gaining community trust
Previous studies, trial aims and the potential role of immunotherapy
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Breaking through barriers in cancer care
A New Standard of Care in Relapsed/Refractory Large B-Cell Lymphoma
Molecular tumor profiling is available to patients
Advertisement
Advertisement